Defzort 24 Tablet

About Defzort 24 Tablet

Defzort 24 is a tablet made by Advanced Chemical Industries PLC. It contains deflazacort 24 mg, a glucocorticoid medicine. Doctors prescribe it for certain inflammatory and immune-related conditions.

There are 28 brands of Deflazacort listed in Bangladesh. The lowest listed price is Dezert 6 mg Tablet at ৳ 8.00 per unit.

What is Defzort 24 Tablet?

Defzort 24 is a tablet manufactured by Advanced Chemical Industries PLC and contains deflazacort 24 mg. Deflazacort belongs to a group of medicines called glucocorticoids. It reduces inflammation by blocking an enzyme involved in prostaglandin production and by lowering the release of immune system chemicals. It is used in conditions such as severe allergic reactions, asthma, rheumatoid arthritis, and some skin and connective tissue disorders. The dose and length of treatment are set by your doctor based on your condition.

Uses of Defzort 24

Defzort 24 is used in adults for a range of inflammatory and immune-related conditions. These include severe allergic reactions, asthma, rheumatoid arthritis, and some connective tissue diseases like lupus. It is also used for certain blistering skin conditions such as pemphigus. Your doctor will decide if this medicine is suitable for you.

How to use Defzort 24

Defzort 24 is a tablet that you take by mouth. Your doctor will decide the dose and how long you need to take it, based on your condition and response. Do not change the dose yourself. If you miss a dose, ask your doctor or pharmacist what to do. Do not stop the medicine suddenly without medical advice.

Side effects of Defzort 24

Like other glucocorticoids, Defzort 24 can cause side effects. These may include stomach upset, muscle and bone problems, hormonal changes, mood or sleep changes, eye problems, and fluid or salt imbalance. It can also increase the risk of infection, slow healing, and cause skin thinning, stretch marks, acne, or blood vessel changes. Tell your doctor if you notice any side effects.

Safety and precautions

Defzort 24 must be used with caution in people with heart disease, high blood pressure, diabetes, stomach ulcers, or a history of blood clots. It can cause salt and water retention, so your doctor may monitor you closely. Do not receive live vaccines while taking this medicine. If you are pregnant, planning pregnancy, or breastfeeding, talk to your doctor first, as corticosteroids may affect the baby. Always tell your doctor about all other medicines you take.

Frequently asked questions

How should I store Defzort 24?

Keep Defzort 24 in a cool, dry place below 25°C, away from light and moisture. Store it out of the reach of children. Do not use after the expiry date.

What is Defzort 24 used for and what kind of medicine is it?

Defzort 24 is a glucocorticoid tablet containing deflazacort 24 mg. It is used to treat inflammatory and immune-related conditions such as severe allergic reactions, asthma, rheumatoid arthritis, and certain skin and connective tissue disorders.

How should I take Defzort 24?

Take Defzort 24 by mouth as directed by your doctor. The dose and duration are decided by your doctor based on your condition. Do not change the dose or stop the medicine without medical advice.

Who should ask a doctor before using Defzort 24?

People with heart disease, high blood pressure, diabetes, stomach ulcers, or blood clotting problems should ask a doctor first. Also ask if you are pregnant, breastfeeding, or taking other medicines, as dose adjustments may be needed.

Indications

Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • ... Read more
Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • Pemphigus,bullous pemphigoid, pyoderma gangrenosum
  • Minimal change nephrotic syndrome, acute interstitial nephritis
  • Rheumatic carditis
  • Ulcerative colitis, Crohn's disease
  • Uveitis, optic neuritis
  • Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura
  • Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma
  • Immune suppression in transplantation

Pharmacology

Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals Deflazacort provides immunosuppressive action.

Dosage & Administration

Adults-
  • For acute disorders: Up to 120 mg/day Deflazacort may need to be given initially. Maintenance doses in most conditions are within the range of 3-18 mg/day.
  • Rheumatoid arthritis: The maintenance dose is usually within the range of 3-18 mg/day. The smallest effective dose should be used and increased if necessary.
  • Bronchial asthma: In the treatment of an acute attack, high doses of 48-72 mg/day may be needed depending on severity and gradually reduced once the attack has been controlled. For maintenance in chronic asthma, doses should be titrated to the lowest dose that controls symptoms.
  • Other conditions: The dose of Deflazacort depends on clinical need titrated to the lowest effective dose for maintenance. Starting doses may be estimated on the basis of ratio of 5 mg prednisone or prednisolone to 6 mg.
Children: There has been limited exposure of children to Deflazacort in clinical trials. In children, the indications for glucocorticoids arethe same as for adults, but it is important that the lowest effective dosage is used. Alternate day administration may be appropriate. Doses of Deflazacort usually lie in the range 0.25-1.5 mg/kg/day.

The following ranges provide general guidance:
  • Juvenile chronic arthritis: The usual maintenance dose is between 0.25-1.0 mg/kg/day.
  • Nephrotic syndrome: Initial dose of usually 1.5 mg/kg/day followed by down titration according to clinical need.
  • Bronchial asthma: On the basis of the potency ratio, the initial dose should be between 0.25-1.0 mg/kg on alternate days.
Deflazacort withdrawal: In patients who have received more than physiological doses of systemic corticosteroids (approximately 9 mg per day or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced.

Interaction

Deflazacort is metabolized in the liver. It is recommended to increase the maintenance dose of Deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, (e.g. ketoconazole) it may be possible to reduce the maintenance dose of Deflazacort.

Contraindications

Hypersensitivity to or any of the ingredients. Patients receiving live virus immunization.

Side Effects

GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent Ml, thromboembolism.

Pregnancy & Lactation

Pregnancy: Deflazacort does cross the placenta. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intrauterine growth retardation. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.

Nursing Mother: Corticosteroids are excreted in breast milk, although no data are available for Deflazacort. Doses of up to 50 mg daily of Deflazacort are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breastfeeding are likely to outweigh any theoretical risk.

Precautions & Warnings

The following clinical conditions require special caution and frequent patient monitoring is necessary-
  • Cardiac disease or congestive heart failure (except in the presence of active rheumatic carditis), hypertension, thromboembolic disorders. Glucocorticoids can cause salt and water retention and increased excretion of potassium. Dietary salt restriction and potassium supplementation may be necessary.
  • Gastritis or oesophagitis, diverticulitis, ulcerative colitis if there is the probability of impending perforation, abscess or pyogenic infections, fresh intestinal anastomosis, active or latent peptic ulcer.
  • Diabetes mellitus or family history, osteoporosis, myasthenia gravis, renal insufficiency.
  • Emotional instability or psychotic tendency, epilepsy.
  • Previous corticosteroid-induced myopathy.
  • Liver failure.
  • Hypothyroidism and cirrhosis, which may increase the glucocorticoid effect.
  • Ocular herpes simplex because of possible corneal perforation.

Storage Conditions

Store in a cool (below 25°C) and dry place, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Deflazacort

Other brands with the same generic name, cheapest first.

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.